<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/62A9A55D-8318-4DBA-9F54-1563897BAA9B"><gtr:id>62A9A55D-8318-4DBA-9F54-1563897BAA9B</gtr:id><gtr:name>Bruker Corporation</gtr:name><gtr:address><gtr:line1>19 Fortune Drive</gtr:line1><gtr:line2>Manning Park</gtr:line2><gtr:postCode>01821</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/7989ED9B-5D1A-4201-A8BD-AB943285E55A"><gtr:id>7989ED9B-5D1A-4201-A8BD-AB943285E55A</gtr:id><gtr:name>National Physical Laboratory NPL</gtr:name><gtr:address><gtr:line1>National Physical Laboratory</gtr:line1><gtr:line4>Teddington</gtr:line4><gtr:line5>Middlesex</gtr:line5><gtr:postCode>TW11 0LW</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/40D8250C-C708-4AD7-B244-058E48DD3B31"><gtr:id>40D8250C-C708-4AD7-B244-058E48DD3B31</gtr:id><gtr:name>Peter MacCallum Cancer Centre</gtr:name><gtr:address><gtr:line1>Smorgon Family Bldg</gtr:line1><gtr:line2>St Andrew's place</gtr:line2><gtr:line4>Melbourne</gtr:line4><gtr:line5>VIC, 3002</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Australia</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/BE5027A2-9A29-4322-AB89-41E0AF3BC9FF"><gtr:id>BE5027A2-9A29-4322-AB89-41E0AF3BC9FF</gtr:id><gtr:name>MedImmune</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/C842A34F-18F7-454D-A259-FED802368496"><gtr:id>C842A34F-18F7-454D-A259-FED802368496</gtr:id><gtr:name>University of Leicester</gtr:name><gtr:address><gtr:line1>University Road</gtr:line1><gtr:line4>Leicester</gtr:line4><gtr:line5>Leicestershire</gtr:line5><gtr:postCode>LE1 7RH</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:department>London Centre for Nanotechnology</gtr:department><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/62A9A55D-8318-4DBA-9F54-1563897BAA9B"><gtr:id>62A9A55D-8318-4DBA-9F54-1563897BAA9B</gtr:id><gtr:name>Bruker Corporation</gtr:name><gtr:address><gtr:line1>19 Fortune Drive</gtr:line1><gtr:line2>Manning Park</gtr:line2><gtr:postCode>01821</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/7989ED9B-5D1A-4201-A8BD-AB943285E55A"><gtr:id>7989ED9B-5D1A-4201-A8BD-AB943285E55A</gtr:id><gtr:name>National Physical Laboratory NPL</gtr:name><gtr:address><gtr:line1>National Physical Laboratory</gtr:line1><gtr:line4>Teddington</gtr:line4><gtr:line5>Middlesex</gtr:line5><gtr:postCode>TW11 0LW</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/40D8250C-C708-4AD7-B244-058E48DD3B31"><gtr:id>40D8250C-C708-4AD7-B244-058E48DD3B31</gtr:id><gtr:name>Peter MacCallum Cancer Centre</gtr:name><gtr:address><gtr:line1>Smorgon Family Bldg</gtr:line1><gtr:line2>St Andrew's place</gtr:line2><gtr:line4>Melbourne</gtr:line4><gtr:line5>VIC, 3002</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Australia</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/BE5027A2-9A29-4322-AB89-41E0AF3BC9FF"><gtr:id>BE5027A2-9A29-4322-AB89-41E0AF3BC9FF</gtr:id><gtr:name>MedImmune</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C842A34F-18F7-454D-A259-FED802368496"><gtr:id>C842A34F-18F7-454D-A259-FED802368496</gtr:id><gtr:name>University of Leicester</gtr:name><gtr:address><gtr:line1>University Road</gtr:line1><gtr:line4>Leicester</gtr:line4><gtr:line5>Leicestershire</gtr:line5><gtr:postCode>LE1 7RH</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/544E2BDC-D120-4048-9CD3-D106009DFA5D"><gtr:id>544E2BDC-D120-4048-9CD3-D106009DFA5D</gtr:id><gtr:name>JPK Instruments AG</gtr:name><gtr:address><gtr:line1>Bouchestrasse 12</gtr:line1><gtr:line4>Berlin</gtr:line4><gtr:postCode>12435</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A5E72F91-30E2-45E6-8D19-EDC197FF970A"><gtr:id>A5E72F91-30E2-45E6-8D19-EDC197FF970A</gtr:id><gtr:name>Monash University</gtr:name><gtr:address><gtr:line1>Monash University</gtr:line1><gtr:line2>Level 1, Chancellery Building D</gtr:line2><gtr:line3>26 Sports Walk, Wellington Road</gtr:line3><gtr:postCode>3800</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Australia</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/32F5D803-A0A3-4420-945F-2E6D71A21C5C"><gtr:id>32F5D803-A0A3-4420-945F-2E6D71A21C5C</gtr:id><gtr:firstName>Bart</gtr:firstName><gtr:otherNames>Wiebren</gtr:otherNames><gtr:surname>Hoogenboom</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=BB%2FJ006254%2F1"><gtr:id>35F9133E-D3C6-444A-B09A-15196AACA9E7</gtr:id><gtr:title>Dynamics and pathways of assembly in membrane pore formation</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>BB/J006254/1</gtr:grantReference><gtr:abstractText>Pore-forming proteins are crucial armaments in the continuous battle between living organisms and the pathogens that threaten their fitness and survival. These proteins act on cells, which are the micrometre-scaled, basic units of all forms of life. Cells are separated and protected from their environment by a thin membrane. Pathogens such as bacteria can release pore-forming proteins (&amp;quot;toxins&amp;quot;) that drill holes in the membranes of healthy cells in the host organism, to release nutrients for the bacteria, to invade these cells and/or kill them. Patients affected by bacterial pneumonia, for example, suffer from the devastating effects of such a toxin, pneumolysin, on lung tissue. The immune system, however, uses a similar mechanism to kill germs and infected or cancerous cells, thus preventing them from doing further damage to the organism. It secretes related, but somewhat different pore-forming proteins to perforate the membranes of such unwanted invaders.

To perform these tasks, pore-forming proteins have developed sophisticated drilling mechanism. These proteins can convert from a soluble form in the aqueous, cellular environment into a very different form, in which 20-50 protein molecules assemble into a ring-shaped pore bound to the membrane. We can look at these forms with X-rays or electrons to deduce their three-dimensional structures. Thanks to such experiments, we now have a reasonably clear picture of the soluble proteins and their pore structure in the membrane. For some pore-forming proteins, scientists have even identified the changes inside the proteins which make this transition possible.

However, if we wish to design drugs that prevent such pores from being formed, as in the example of bacterial pneumonia indicated above, it would be useful to know more about the steps in their formation. It is exactly this pore assembly that is still largely enigmatic. In this project, we will try to answer some specific questions about membrane pore formation. We would like to know how the proteins assemble on the membrane. Do they assemble one by one, or do they first form larger units that subsequently assemble in a pore? Do the proteins first need to assemble on the membrane, or can they dock in the membrane and assemble in pores afterwards? And at what point in this process will the membrane that is surrounded by the assembled protein be extruded to create a hole?

To investigate the dynamics of this process, we rely on a technique called atomic force microscopy. Atomic force microscopy is the small-scale equivalent of reading Braille: With a tiny artificial finger, we feel the pore-forming proteins while they assemble on the membrane. Whereas X-ray crystallography and electron microscopy are limited to static samples, atomic force microscopy can probe active proteins while they are at work. We will thus apply atomic force microscopy to the membranes that are being exposed to attack by pore-forming proteins. Meanwhile, we will benefit from the more detailed views provided by electron microscopy to identify intermediate assemblies of pore-forming proteins, that are trapped by chemical bonds or by lowering the temperature. Electron microscopy will thus provide highly detailed pictures of pore forming proteins in different states of assembly and atomic force microscopy will enable us to see how the proteins transit between these different states.</gtr:abstractText><gtr:technicalSummary>We will use real-time atomic force microscopy (AFM), single particle electron microscopy (EM) and electron tomography to track the dynamics and the pathways of assembly of pore-forming proteins on and in membranes. We will focus on the superfamily of cholesterol dependent cytolysins (CDCs) and membrane attack complex/perforin (MACPF) pore-forming proteins. Though atomic structures of CDC and MACPF proteins have been determined for the soluble monomers, along with low resolution maps of the membrane-inserted pores, the dynamics and pathways of assembly are much harder to address experimentally. To find assembly pathways, we will trap intermediate assemblies with disulphide locked variants and reduced temperatures, and determine their structures by EM. Moreover, benefitting from recent developments on fast-scanning AFM, we will follow the assembly and pore formation by real-time imaging of the functional proteins on planar-supported model membranes. Combining the two methods, we will determine the sequential steps in the assembly of the prepore and pore state of bacterial CDCs and of the MACPF protein perforin. By probing inside the rings with AFM, we will also investigate the fate of the lipid bilayer in the pores upon assembly of bacterial CDCs. We will elucidate biophysical mechanisms that are fundamental to pathogen attack and immune defence. This information is anticipated to create opportunities for new drug design, either by stabilising pore-forming proteins to prevent pore formation, or in stabilising or enhancing their membrane-bound forms, in case of deficient pore-forming activity.</gtr:technicalSummary><gtr:potentialImpactText>This proposal aims at elucidating the biological and biophysical mechanisms of membrane pore formation by bacterial toxins and immune mediators. The superfamily of membrane attack complex/perforin (MACPF) and cholesterol-dependent cytolysin (CDC) proteins that it focuses on are of significant medical importance. The CDC perfringolysin O rapidly induces irreversible cellular injury in a deadly form of gangrene that is caused by the bacterium Clostridium perfringens. The CDC pneumolysin is a major virulence factor of Streptococcus pneumoniae, at the root of bacterial pneumonia, still a major cause of death and illness throughout the world despite the widespread use of antibiotics. When released in the lungs, pneumolysin damages the lung tissue and its blood vessels. Antibiotics may exacerbate lung damage because they are designed to kill the bacteria by breaking them open, which leads to the further release of pneumolysin. Perforin is the main weapon of natural killer cells. It punches holes in virally infected or cancerous cells that have been detected by the immune system, and delivers lethal granzymes through these holes. Babies born with defective perforin succumb to viral infections or tumours early in life. On the other hand, if perforin is too active, normal cells can be incorrectly killed.

By elucidating the mechanism of membrane pore formation by pore-forming proteins, we will create new opportunities for drug design: e.g., the prevention of pore formation by pneumolysin would be a significant advance in the treatment of bacterial pneumonia; the ability to control the activity of MACPF proteins in the human immune system could be an important means of regulating the immune response during and after tissue and organ transplantation or could alleviate the perforin-dependent cytotoxicity in autoimmune diabetes.

In addition, the proposed methodology for studying membrane pore formation is not restricted to pore-forming proteins alone. It can be applied to a variety of other medically relevant interactions between membranes and macromolecules. Examples of this are antimicrobial peptides that are currently investigated as new therapies against bacterial infections, as well as pH-sensitive polymers that are used for intracellular drug (e.g., gene and RNA therapies) delivery across the barrier formed by endosomal membranes after cellular drug in-take via endocytosis. We anticipate that the development of such novel therapeutic approaches will be enhanced by molecular-scale understanding as can be achieved with the methods outlined in this proposal.

On the shorter term (several years), this research will thus benefit pharmaceutical industry and biomedical SMEs. On the longer term (10-20 years, given the lead times for drug development), it will have an impact on healthcare practitioners and patients.

Further impact can be achieved on the AFM technology. With this project, we propose a new application of fast-scanning AFM techniques that have only recently been developed. For such a young technology, feedback based on relevant applications is crucial. It helps to adjust the technology such that it can make a larger impact over a wider range of applications, which will benefit nanotechnological SMEs.

Given the power of high-quality images and movies such as can be produced by in particular AFM, we also anticipate an educational impact to the lay audience by demonstrating a powerful and biomedically relevant application of basic sciences and nanotechnology.</gtr:potentialImpactText><gtr:fund><gtr:end>2015-04-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/2512EF1C-401B-4222-9869-A770D4C5FAC7"><gtr:id>2512EF1C-401B-4222-9869-A770D4C5FAC7</gtr:id><gtr:name>BBSRC</gtr:name></gtr:funder><gtr:start>2012-05-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>263984</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs><gtr:artisticAndCreativeProductOutput><gtr:description>Inspired by our research on imaging DNA by high-resolution atomic force microscopy, British artists AL and AL made a ski-fi artistic film, named The Demiurge, which has its world premiere February 2016 in a widely attended artistic exhibition in Manchester, and which was co-funded by the Wellcome Trust.</gtr:description><gtr:id>B65A0629-BC34-434F-B429-D52BCF08392E</gtr:id><gtr:impact>Over 4000 visitors in first week of exhibition.</gtr:impact><gtr:outcomeId>56cf14643b1a56.73209949</gtr:outcomeId><gtr:title>Film The Demiurge inspired by our research</gtr:title><gtr:type>Film/Video/Animation</gtr:type><gtr:url>http://homemcr.org/exhibition/al-al-incidents-of-travel-in-the-multiverse/</gtr:url><gtr:yearFirstProvided>2016</gtr:yearFirstProvided></gtr:artisticAndCreativeProductOutput></gtr:artisticAndCreativeProductOutputs><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>MedImmune</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>MedImmune</gtr:description><gtr:id>0DE874BC-112D-4AC1-A987-42BA6BCAF677</gtr:id><gtr:impact>The results are largely confidential, but include understanding of the working mechanisms of monoclonal antibody drugs targeting cell surface receptors.
In addition, MedImmune has committed to provide a financial contribution in an application for a BBSRC Industrial PartnerShip Award, if this is funded (currently under review).</gtr:impact><gtr:outcomeId>54608a7ec6a970.10219075-1</gtr:outcomeId><gtr:partnerContribution>Technical advise, PhD student supervision, purified proteins, financial contributions (cash) to support research.</gtr:partnerContribution><gtr:piContribution>Imaging of cell surface receptors, to help MedImmune (Cambridge) understand the mechanisms by which monoclonal antibody drugs target cell surface receptors.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Leicester</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>University of Leicester</gtr:description><gtr:id>CD6C175E-FF61-41A4-A34A-2BBCCFA6BF84</gtr:id><gtr:impact>Insights in pathways of membrane pore formation by the bacterial toxin suilysin (manuscript under review).</gtr:impact><gtr:outcomeId>546089518006d2.09042435-1</gtr:outcomeId><gtr:partnerContribution>Provision of purified proteins.</gtr:partnerContribution><gtr:piContribution>Insights in mechanism of bacterial toxins that are subject of drug development programmes in Leicester</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Physical Laboratory</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>National Physical Laboratory</gtr:description><gtr:id>61B1541E-8E42-43B9-B224-A2FC0267BD5A</gtr:id><gtr:impact>Multidisciplinary, involving physicists, chemists, bioengineers, and biologists.
This collaboration has helped to put forward antimicrobial peptides as (potential) next-generation antibiotics.</gtr:impact><gtr:outcomeId>56cc8262429685.88779265-1</gtr:outcomeId><gtr:partnerContribution>Design of antimicrobial peptides.
Expertise.</gtr:partnerContribution><gtr:piContribution>We have provided the technology to visualise how next-generation antibiotics (de-novo designed antimicrobial peptides) attack bacteria.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Imperial College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Imperial College Trust</gtr:department><gtr:description>Imperial College London</gtr:description><gtr:id>D642404E-D5D7-4E30-97A8-70F5E3A0B97F</gtr:id><gtr:impact>This is a multi-disciplinary collaboration, involving physicists, chemists, engineers and biologist.
It is still rather early to highlight particular outcomes.</gtr:impact><gtr:outcomeId>56cc80efef9079.81795385-1</gtr:outcomeId><gtr:partnerContribution>Nanopore devices.
Purified proteins.
Expertise.</gtr:partnerContribution><gtr:piContribution>Based on our research on the biological nuclear pore complex, we have proposed mechanisms via which artificial nanopores may be designed as selective valves. With collaborators at Imperial College, we currently attempt to implement these ideas in a working system.

On a different topic, our work on pore forming proteins has helped us to initiate a collaboration with structural biologists at Imperial College, where we attempt to use similar methodology to elucidate mechanism via which the immune system attacks bacteria.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Bruker Corporation</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:department>Bruker Nano</gtr:department><gtr:description>Industrial collaboration with AFM manufacturer Bruker Nano</gtr:description><gtr:id>AA0CA94C-556A-4B5E-91B4-8112B1CB763A</gtr:id><gtr:impact>Multidisciplinary - involving engineering, physics and biology.
Outcomes of broad and general use are protocols and instructions for double-helix-resolution imaging of DNA in liquid, see, e.g., a webinar on this (http://www.bruker.com/service/education-training/webinars/afm.html), which helps AFM manufacturer Bruker and its representation in the UK. Technical feedback from our side has helped Bruker to optimise its products before and after market release.
Another outcome is the visualisation of membrane lesions and of prepore-state bacterial toxins diffusing on a membrane surface, elucidating the pathways of membrane pore formation by bacterial toxins, as well as understanding of mechanism by which antimicrobial peptides (potential next-generation antibiotics) attack bacteria.</gtr:impact><gtr:outcomeId>b960ae1eb960ae3c-1</gtr:outcomeId><gtr:partnerContribution>Provision of and access to latest commercial AFM equipment (including beta-version pre market release), provision of AFM proves, all at zero or greatly reduced price.</gtr:partnerContribution><gtr:piContribution>Following successful high-resolution atomic force microscopy (AFM) imaging, we have signed a joint development agreement with world-leading AFM manufacturer Bruker Nano (formerly Veeco, formerly Digital Instruments), on testing and developing protocols on prototype AFM equipment. Bruker Nano contributes in-kind to this project. Our work with their instrumentation and probes has provided Bruker with AFM images of the DNA double helix (and protocols for acquiring these), as well as an assessment of probe tip sharpness (both by benchmarking on DNA and on assemblies of pore forming proteins.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Peter MacCallum Cancer Centre</gtr:collaboratingOrganisation><gtr:country>Australia, Commonwealth of</gtr:country><gtr:description>Peter MacCallum Cancer Centre</gtr:description><gtr:id>816E0801-7873-467A-96E9-A7CE8FAC11A0</gtr:id><gtr:impact>Work in progress still.</gtr:impact><gtr:outcomeId>546089e7ecd685.24693458-1</gtr:outcomeId><gtr:partnerContribution>Scientific advise and purified proteins.</gtr:partnerContribution><gtr:piContribution>Insights in the pathways of membrane pore formation by perforin, a component of the human immune system.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Lego4Nano workshop in Beijing</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>F9557F9C-C3A9-4F61-A186-858E59416A21</gtr:id><gtr:impact>My PhD students provided the expertise in atomic force microscopy that was essential in this UK-China workshop, sponsored by Lego, to build a low-cost microscope

the workshop was widely reported in the media, including Chinese national newspapers.</gtr:impact><gtr:outcomeId>5460992f1d7836.28423755</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.london-nano.com/news-and-events/news/2014-lego2nano-launches</gtr:url><gtr:year>2013,2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Food industry talks</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>0D7A8DD0-CFEA-4347-8C65-8B0DF3FAF4C4</gtr:id><gtr:impact>At Leatherhead Food Research and at Mars Corporation, talk on nanotechnology sparked questions about the use of it for food industry.

Follow-up emails.</gtr:impact><gtr:outcomeId>54609a46159806.58501176</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2012,2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>School talks</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>7F44C054-62CB-4064-9D35-9C2BA95845CD</gtr:id><gtr:impact>Our school talks typically sparked questions and discussions about nanotechnology, about physics and biology.

Follow-up emails.</gtr:impact><gtr:outcomeId>546099be7837f8.41946952</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2009,2010,2011,2012,2013</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>711385</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>EPSRC Equipment Funding</gtr:description><gtr:end>2016-03-02</gtr:end><gtr:fundingOrg>Engineering and Physical Sciences Research Council (EPSRC)</gtr:fundingOrg><gtr:fundingRef>EP/M028100/1</gtr:fundingRef><gtr:id>081A825A-5F7A-4A1F-8851-C818FCE5995F</gtr:id><gtr:outcomeId>56cc83f39d5097.40142361</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>10000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>BBSRC Impact Award</gtr:department><gtr:description>Impact Acceleration Account</gtr:description><gtr:end>2016-09-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:fundingRef>BB/IAA/UCL/15</gtr:fundingRef><gtr:id>4E96FEAD-543E-44C0-B5B9-7AF6007D3E37</gtr:id><gtr:outcomeId>58c7f841e93a45.14701271</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>458449</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Responsive mode grant</gtr:description><gtr:end>2019-10-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:fundingRef>BB/N015487/1</gtr:fundingRef><gtr:id>ED44128D-ABA7-4E36-988A-7F119F318B53</gtr:id><gtr:outcomeId>58beac4f3e8177.06926320</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2016-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>102000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BBRSC CASE PhD studentship</gtr:description><gtr:end>2018-09-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:fundingRef>BB/M503113/1</gtr:fundingRef><gtr:id>E8B67C2A-EC36-4BE2-BE66-0559B6AB98D2</gtr:id><gtr:outcomeId>54608b48ebbd75.68378034</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2014-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs><gtr:impactSummaryOutput><gtr:description>Methodology developed in this grant has been translated to experiments on novel antimicrobial peptides developed at NPL, and helped to elucidate their functional mechanisms as antibiotics.</gtr:description><gtr:firstYearOfImpact>2013</gtr:firstYearOfImpact><gtr:id>E87C3BB1-23C3-47BC-92E6-C593E89D61EE</gtr:id><gtr:impactTypes><gtr:impactType>Societal</gtr:impactType></gtr:impactTypes><gtr:outcomeId>5460a0857fed44.02277104</gtr:outcomeId><gtr:sector>Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:impactSummaryOutput></gtr:impactSummaryOutputs><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>We have viewed bacterial nanodrills in action. Briefly, bacteria can gain access to food held in a healthy cell by perforating its protective membrane. We have imaged the nanodrills that do this peroration and gained insights into their way of operation.</gtr:description><gtr:exploitationPathways>The obtained understanding can be used to optimise drug development programmes against, e.g., bacterial pneumonia.</gtr:exploitationPathways><gtr:id>2663B8BF-370B-4C10-949F-E5A36251BBD6</gtr:id><gtr:outcomeId>5460a056278280.35080117</gtr:outcomeId><gtr:sectors><gtr:sector>Healthcare,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:sectors><gtr:url>https://www.ucl.ac.uk/mathematical-physical-sciences/maps-news-publication/maps1434</gtr:url></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Atomic force microscopy techniques to visualise DNA / nucleic acid / oligonucleotidedouble helix structure</gtr:description><gtr:id>ED34A68F-D3F7-4CCD-8C3F-ACCD9046FF14</gtr:id><gtr:impact>Related work has benefitted industrial research by MedImmune (branch of AstraZeneca) and Syngenta.</gtr:impact><gtr:outcomeId>54609ac7e82668.07116370</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>High-resolution atomic force microscopy</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2013</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>F2143B9B-20C6-4806-BDB2-F54D03AC3D79</gtr:id><gtr:title>Atomic force microscopy of membrane pore formation by cholesterol dependent cytolysins.</gtr:title><gtr:parentPublicationTitle>Current opinion in structural biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7c7eab73a113dee5faf14025241d9c24"><gtr:id>7c7eab73a113dee5faf14025241d9c24</gtr:id><gtr:otherNames>Hodel AW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0959-440X</gtr:issn><gtr:outcomeId>58be9c34390303.12670090</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5958F239-855E-4F62-8BA7-7BAAA2BAF118</gtr:id><gtr:title>Engineering monolayer poration for rapid exfoliation of microbial membranes.</gtr:title><gtr:parentPublicationTitle>Chemical science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3df7085a2ec16c3e9e1569f8f42bfeb8"><gtr:id>3df7085a2ec16c3e9e1569f8f42bfeb8</gtr:id><gtr:otherNames>Pyne A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2041-6520</gtr:issn><gtr:outcomeId>585d38ebaa5f46.48867412</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E03B6AF7-1616-4843-ADA5-82B8FE698317</gtr:id><gtr:title>Enhanced quality factors and force sensitivity by attaching magnetic beads to cantilevers for atomic force microscopy in liquid</gtr:title><gtr:parentPublicationTitle>Journal of Applied Physics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/512dd7436f8b3079b96dc17b8db3a368"><gtr:id>512dd7436f8b3079b96dc17b8db3a368</gtr:id><gtr:otherNames>Hoof S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>5460845fbfa703.57529706</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>95E18A7B-5DD1-48F4-83F0-F7D82F0AA919</gtr:id><gtr:title>Antimicrobial peptide capsids of de novo design.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/edeb9e14ed43e1eb60bad699f7af1b0c"><gtr:id>edeb9e14ed43e1eb60bad699f7af1b0c</gtr:id><gtr:otherNames>De Santis E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>5a9fda4cb2e655.55050148</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C896B3FF-650D-4F7C-9E47-9269BC4BFF50</gtr:id><gtr:title>Reversible Dissolution of Microdomains in Detergent-Resistant Membranes at Physiological Temperature.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8faa8b49dde70f703d0415ffcc57f918"><gtr:id>8faa8b49dde70f703d0415ffcc57f918</gtr:id><gtr:otherNames>Cremona A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>585d75c3a072a2.76993061</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AF429948-3414-433E-9917-4B6D5B98B97A</gtr:id><gtr:title>Physical modelling of the nuclear pore complex</gtr:title><gtr:parentPublicationTitle>Soft Matter</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e2804be1b5e616d83df30d50df62165a"><gtr:id>e2804be1b5e616d83df30d50df62165a</gtr:id><gtr:otherNames>Osmanovic D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:outcomeId>5460845f989751.53039564</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5C28F409-71A0-4334-8200-868A7DD694EB</gtr:id><gtr:title>Stepwise visualization of membrane pore formation by suilysin, a bacterial cholesterol-dependent cytolysin.</gtr:title><gtr:parentPublicationTitle>eLife</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/12d8588715cacc003c5707b7802a6355"><gtr:id>12d8588715cacc003c5707b7802a6355</gtr:id><gtr:otherNames>Leung C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2050-084X</gtr:issn><gtr:outcomeId>doi_55f94b94ba73bf3a</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>493CD80E-D638-4CCC-9483-C653E8F8515D</gtr:id><gtr:title>The membrane attack complex, perforin and cholesterol-dependent cytolysin superfamily of pore-forming proteins.</gtr:title><gtr:parentPublicationTitle>Journal of cell science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f44bf8fdce5ad73ddaa57b120a3dc654"><gtr:id>f44bf8fdce5ad73ddaa57b120a3dc654</gtr:id><gtr:otherNames>Lukoyanova N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0021-9533</gtr:issn><gtr:outcomeId>585d3eeee7b9e5.25425977</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6DA2A8AD-65F4-463B-86A2-F1DFACD2AFA2</gtr:id><gtr:title>Real-time visualization of perforin nanopore assembly.</gtr:title><gtr:parentPublicationTitle>Nature nanotechnology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/12d8588715cacc003c5707b7802a6355"><gtr:id>12d8588715cacc003c5707b7802a6355</gtr:id><gtr:otherNames>Leung C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1748-3387</gtr:issn><gtr:outcomeId>58be9fe7d47345.56811637</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9845390F-1FB6-4E90-9560-0B76763E0184</gtr:id><gtr:title>Structurally plastic peptide capsules for synthetic antimicrobial viruses.</gtr:title><gtr:parentPublicationTitle>Chemical science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/eb145344eaa7cf0c2033992c0c10ec6c"><gtr:id>eb145344eaa7cf0c2033992c0c10ec6c</gtr:id><gtr:otherNames>Castelletto V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2041-6520</gtr:issn><gtr:outcomeId>58be9c358b32c8.07024139</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">BB/J006254/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects><gtr:researchSubject><gtr:id>F442B6BE-8B89-4C01-8D3B-E8A4D320B672</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Biomolecules &amp; biochemistry</gtr:text></gtr:researchSubject><gtr:researchSubject><gtr:id>6BF947B0-8E6E-48DB-AB68-7130938F2DF2</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Instrument. sensor &amp; detectors</gtr:text></gtr:researchSubject><gtr:researchSubject><gtr:id>E847DD9B-2053-4BC7-97A9-4213B185C968</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Materials sciences</gtr:text></gtr:researchSubject></gtr:researchSubjects><gtr:researchTopics><gtr:researchTopic><gtr:id>D22AE401-1C35-4706-A19C-10861ABC82CD</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Biological membranes</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>02FE9751-1497-4DFD-B349-D4A9C96538E1</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Biophysics</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>F78E4567-DD59-4364-9D1F-0A778996E941</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Instrumentation Eng. &amp; Dev.</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>561091A1-9FC9-4508-B1B2-2F3623E1FC9D</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Materials Characterisation</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>1163A5D2-CE35-4C7E-904E-6FB2B5FA0C2A</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Multiprotein complexes</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>